James T Maddux, MD Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 500 W Broadway St, Suite 320, Missoula, MT 59802 Phone: 406-329-5615 Fax: 406-329-5606 |
Dr. Michael Wayne Yerkey, M.D., F.A.C.C. Internal Medicine - Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 500 W Broadway St, Missoula, MT 59802 Phone: 406-329-5615 Fax: 406-329-2791 |
News Archive
Among the many challenges to independence and quality of life after spinal cord injury, two complications have emerged as top priorities for researchers - neurogenic bowel and neurogenic bladder.
Caraco Pharmaceutical Laboratories, Ltd., has announced that the US Food and Drug Administration (FDA) has granted final approval for the Company's Abbreviated New Drug Application (ANDA) for Glipizide/Metformin Hydrochloride Tablets, 2.5/250 mg, 2.5/500 mg and 5/500 mg (Glipizide/Metformin HCl).
Investigators at Children's Hospital Los Angeles have found that significant bone loss - a side effect of chemotherapy for acute lymphoblastic leukemia (ALL) - occurs during the first month of treatment, far earlier than previously assumed. Results of the study will be available online February 4, in advance of publication in the journal Bone.
Critics are up in arms over America's Health Insurance Plans (AHIP) daring to speak the truth about the Senate health care reform proposal, and we applaud the organization's efforts. If anything AHIP's analysis of health premium increases is too low. Supporters of the health bills are simply ignoring years of states' evidence of many of these proposed Senate and House health reforms.
› Verified 1 days ago